BNET Industries

Market Cap:$332.1M
Last Fiscal Year Sales:$42.3M
  • Public
Dow Jones Description

Otish Resources, Inc. is a Delaware corporation formed in February, 2003. Otish Resources, Inc. is a mineral exploration stage company. The Company has specialized in acquiring and consolidating mineral properties with potential to have commercial ore bodies. Our property acquisition emphasis has focused on properties with diamonds and other strategic minerals that are located in Quebec, Canada. Since the Company is an exploration stage company there is no assurance that a commercially viable mineral deposit exists on any properties which it currently owns. Further, exploration will be required before a final evaluation as to the economic and legal feasibility is determined. The Company initially acquired three properties located in NTS Areas 33A02 (Lac Lavallette), 23D04 (Lac Laparre) and 33A01 (Lac Barou) of the Otish Mountains diamond exploration area in Baie James Region in Northern Quebec. The claims were staked by Mr. Lee Barker , MSc. PEng., PGeol., based on an interpretation of reprocessed Canadian government aeromagnetic survey data. All claim groups require further exploration to assess their potential to host discrete intrusives that could be similar to the diamondiferous kimberlite bodies recently discovered in the region.

Number of Employees 360
Contact Information

999 Ningqiao Road Jinqiao Export Processing Zone

Shanghai 201206

www.chn-biotics...

(86) 21 58349748

NAICS Code Food (Health) Supplement Stores: 446191

Recent Events

  • Build Your Fortune With These Winners

    11/25/09 - Bond / Stock Rating - View Story

  • China-Biotics Slips To Q2 Loss - Update

    11/17/09 - Financial Announcement - View Story

  • China-Biotics, Inc. Reports FY10 Q2 Results

    11/17/09 - Mgmt. Change Leaving - CFO - View Story

  • China-Biotics Inc elects Dr. Tom Gu as vice president

    11/02/09 - Mgmt. Change Entering - Vice President - View Story

  • China-Biotics Reports Resignation Of Lewis Fan As CFO - Quick Facts

    10/23/09 - Mgmt. Change Leaving - Other - View Story

  • China-Biotics CFO resigns to purse other interests

    10/23/09 - Mgmt. Change Leaving - CFO - View Story

  • China-Biotics raises $69 million in public offering of common stock

    10/07/09 - New Investment - View Story

  • Todays Zacks Rank Momentum Buy: China Biotics Inc.

    9/30/09 - Financial Announcement - View Story

News & Analysis

china-biotics inc. - All News and Analysis

  • China-Biotics: An Undervalued Stock with a Growth Catalyst

    Seeking Alpha - 2009-08-26

    China-Biotics Inc. CHBT may not be in the most glamorous business dealing with bacteria, but its stock appears quite appetizing for investors. The company is one of the few domestic producers of probiotics in a baby formula market that primarily relies on imports, while it is also rapidly expanding its...

    Tags: Healthcare, China, Simon Monger, China-Biotics Inc.

  • China-Biotics Reports Gains in FY2009

    Seeking Alpha - 2009-07-15

    ChinaBio Today submits: China-Biotics, Inc. (NSDQ: CHBT) reported positive financial results for its 2009 fiscal year, which ended in March. Sales rose 28% to $54.2 million, and non-GAAP net income climbed 19% to $16.9 million, a very healthy margin of 31%. Revenues were in line with analysts’ expectations, but...

    Tags: China, ChinaBio Today, China-Biotics Inc.

  • China-Biotics's Q3 Shows Improvement

    Seeking Alpha - 2009-02-17

    ChinaBio Today submits: China-Biotics, Inc. CHBT released its Q3 financial report, showing that, compared to last’s years Q3, revenues climbed 33% to $15.8 million while net income rose 40% to $5.7 million. The company, which makes probiotic products, attributed its improved performance to a combination of new products and...

    Tags: China, ChinaBio Today, China-Biotics Inc.

  • Four Probiotic Products Added to China-Biotics' Lineup

    Seeking Alpha - 2009-01-21

    ChinaBio Today submits: China-Biotics, Inc. (NSDQ: CHBT) received manufacturing certificates from the SFDA for several additions to its probiotic line of products. These include Synbiotics Capsules, Probiotics Gegen Capsules, Probiotics Tremella Polysaccharide Capsules and Probiotics Chewable Tablets. Probiotics are live microbial food supplements designed to promote intestinal microbial balance....

    Tags: China, ChinaBio Today, China-Biotics Inc.

  • China-Biotics Delays Plant Construction on Regulatory Conflicts

    Seeking Alpha - 2009-01-14

    ChinaBio Today submits: China-Biotics, Inc. CHBT, a probiotics company, reported that construction of its new manufacturing plant in Shanghai has been delayed. The company blamed the delay on regulatory conflicts. Two agencies have jurisdiction over the facility, the SFDA and the Shanghai Municipal Bureau of Quality and Technical Supervision,...

    Tags: China, ChinaBio Today, China-Biotics Inc.

Decision Makers

Name (plus bio) Position
Crocker Coulson President
Lewis Fan CFO
Raymond Li Chief Financial Officer
Yihong Yan Chief Administrative Officer MS
Weida Huang

Board of Directors

Name (plus bio) Position
Chin Ji Wei Board of Directors
Du Wen Min Board of Directors
Ji Wei Chin Board of Directors
Simon Yick Board of Directors

Organization Position Status
China-Biotics, Inc President Current

Mr. Fan has served as Chief Financial Officer since 2009. Prior to joining China-Biotics, Mr. Fan was Vice President and Senior Equity Analyst for Brean Murray, Carret & Co., where he covered the Chinese healthcare industry. He previously served as an equity analyst at UBS and as an emerging markets strategist at Deutsche Bank. Prior to his Wall Street career, Mr. Fan served as a research scientist focusing on natural product drug discovery at Schering-Plough. He holds a Master of Business Administration degree in finance from New York University, a Master of Science degree in medicinal chemistry from the University of Michigan and a Bachelor of Arts degree with honors in biology and chemistry from Luther College.

Organization Position Status
China-Biotics, Inc CFO Current

Array

Organization Position Status
China-Biotics, Inc Chief Financial Officer Current

Yihong Yan, Chief Administrative Officer Ms. Yan is the CAO (assistant to the general manager) of China-Biotics. She has served as a director since 1999. She was appointed CAO in 2004, and her term will expire in 2008. During the past five years, Ms. Yan has participated in formulating the Company's development plans, implemented internal control procedures and represented the Company in business negotiations with relevant government authorities and other external parties.

Organization Position Status
China-Biotics, Inc Chief Administrative Officer MS Current

Weida Huang, Technical Advisor Dr. Huang co-founded Shining and is a member of the Company's technical advisory panel responsible for product development and applications. Since 1990, he has taught at Fudan University's School of Life Science as an instructor for doctoral students. Dr. Huang is renowned for his studies and research in life science; his research work has earned him a number of research and development awards.

Organization Position Status
Shining Ltd. Founder Current
China-Biotics, Inc Current

Organization Position Status
China-Biotics, Inc Board of Directors Current

Dr. Du has served in this role since January 2007. He has served as the Deputy Director in charge of the Centre for Adverse Drug Reactions in Shanghai since 2001. Dr. Du has also served as the Vice Chairman of Evaluation of Pharmacology & Clinical Pharmacy in Shanghai and the Vice Chairman at the Centre for the Study of Liver Disease in Shanghai since 2006.

Organization Position Status
China-Biotics, Inc Board of Directors Current

Dr. Ji Wei Chin, Independent Director a " Dr. Chin has served in this role since January 2007. Dr. Chin has more than 20 years of academic experience as a lecturer and researcher in the field of horticulture.

Organization Position Status
China-Biotics, Inc Board of Directors Current

Mr. Yick has served in this role since January 2007. He has more than 20 years of experience in corporate finance, direct investment and auditing.

Organization Position Status
China-Biotics, Inc Board of Directors Current

Executive News

  • China-Biotics, Inc. to Attend the SIG 3rd Annual Beijing Management Summit

    Reuters - 9/04/09 - View Story

  • China-Biotics, Inc. to Attend the SIG 3rd Annual Beijing Management Summit

    PR Newswire - 9/04/09 - View Story

advertisement
CHBT $14.85 +0.17 (1.16% )
Volume 161,931
Shares Outstanding 22.3M
Market Cap 332.1M
Year High 19.00
Year Low 5.42
Earnings Per Share 0.75
P/E Ratio 19.80
Dividend 0.00
Yield 0.00
advertisement
Click Here